×

What Helix TCS Merger with BioTrackTHC Means for Investors, Plus Exclusive CEO Video Interview -- CFN Media

SEATTLE, WA, March 21, 2018 (GLOBE NEWSWIRE) -- CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article covering Helix TCS Inc.'s (OTCQB: HLIX) recently announced merger agreement with Bio-Tech Medical Software Inc., dba BioTrackTHC, after acquiring a growing stake in the firm over the past several quarters. The move helps create one of the most promising pure play ancillary businesses in the burgeoning cannabis industry. Also included is an exclusive video interview, filmed just prior to the merger announcement, with company CEO Zachary L. Venegas.

Many investors look at the cannabis industry and see opportunities for cultivators (growers) and dispensaries (retailers). But, there are many other types of companies that are well positioned to profit from the industry’s substantial growth rates. Many of these companies also sidestep the risks assumed by growers and retailers that must touch the federally-illegal drug, which makes them a compelling addition to a well-rounded portfolio.

Ancillary Businesses

The cannabis industry is projected to reach $50 billion by 2026, according to Cowen & Co., driven by the legalization of adult-use and medical cannabis across a growing number of states. While many investors are focused on cultivators and dispensaries, ancillary businesses are poised to capture an even larger share of the market without the legal and financial risks that apply to working directly with the cannabis plant.

Helix TCS has focused on providing integrated operating environment solutions to the legal cannabis industry, including transportation, armed and unarmed guarding, training, investigation, and special services. At the same time, the company’s Cannabase is the oldest and largest wholesale platform in the industry, helping over 72 percent of all cannabis licensees in Colorado improve their sales and marketing efforts.

BioTrackTHC develops and licenses product traceability, inventory management, and point-of-sale software systems for the legal cannabis industry. With nine government contracts and over 2,200 installed systems, the company has become a leader in software systems that enable government regulators and licensed operators to track and capture data on cannabis from the point of inception through the product life cycle.

Potential Synergies

By leveraging its existing client base, the company has been rapidly growing its Cannabase operations, which provides proprietary insights into the industry. These insights are quickly becoming a key asset in the highly competitive market where cultivators and dispensaries are willing to pay for an edge.

“The synergies between Cannabase and BioTrack are significant and we will use them as a starting point for an industry defining platform,” said Helix TCS CEO Zachary L. Venegas in the press release announcing the merger. “The combined firm’s increased scope, linked with our focus on execution, will continue to set the standard for M&A in the industry. We are confident that this merger will enable the combined companies to accelerate growth.”

Cannabase can provide real-time market insights to wholesale growers and retailers, which helps them anticipate market trends, price changes, and volume fluctuations in both the adult-use and medical markets. In addition, the platform provides analytics to advertisers that are looking to market to growers and dispensaries, which helps them optimize their product and service offerings to match what these companies - and consumer demand - requires.

Looking Ahead

Helix TCS Inc. (OTCQB: HLIX) represents a compelling investment opportunity in the burgeoning cannabis industry. After its BioTrackTHC merger, the company has become perhaps the largest ancillary products and services provider, while setting the stage to capture unmatched data fields across the cannabis value chain. The latter development is important to companies who value the ability to use data and analytics to improve their business operations and predictive analytics.

Please follow the link to read the full article: http://www.cannabisfn.com/helix-tcs-merger-biotrackthc-means-investors-plus-exclusive-ceo-video-interview/

For more information, visit the company’s website at www.helixtcs.com.

About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/


CFN Media Frank Lane 206-369-7050 flane@cannabisfn.com

Source: CFN Media

More From Press Releases